Controladores

More documents

Recommendations

Info

Individual Difference in Asthma-Free Days Response Zeiger et al. JACI 117:45, 2006 Participants Better Response to Montelukast (n=15) Better Response to Fluticasone Propionate (n=36) -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6 Difference in Asthma Free Days Response (Fluticasone Propionate – Montelukast) 7
Differential Response Analysis: Asthma-Free Days Greater response to fluticasone over montelukast was associated with the following baseline asthma feature: • Higher eNO Zeiger et al. JACI 117:45, 2006
Page 1 and 2: Estrategias Preventivas y Terapéut
Page 3 and 4: Objetivos del tratamiento del asma
Page 5 and 6: Solo el 2.4 % de los pacientes alca
Page 7 and 8: • Farmacocinética-dinamia • Ef
Page 9 and 10: CELLULAR EFFECTS OF CORTICOSTEROIDS
Page 11 and 12: Goals of Steroid Treatment in Asthm
Page 13 and 14: ß 2 -Receptor mRNA (% change) EFFE
Page 15 and 16: Medications for asthma can be admin
Page 17 and 18: The Fate of Inhaled Corticosteroids
Page 19 and 20: Inflammatory Effects of Leukotriene
Page 21 and 22: Asthma / Wheezing in the First 6 yr
Page 23 and 24: INDICE PREDICTIVO DE ASMA* CRITERIO
Page 25 and 26: Alternativas Farmacológicas Rescat
Page 27 and 28: Persistent Asthma Long Term Control
Page 29 and 30: Protocol Overview Assessment/ Chara
Page 31 and 32: Primary Outcome: FEV1 Response Szef
Page 33 and 34: Differential Response Analysis: FEV
Page 35 and 36: Asthma-Free Days: Definition • No
Page 37: Individual Difference in Asthma-Fre
Page 41 and 42: Dosis Diarias Comparativas Estimada
Page 43 and 44: 7-11 years’ treatment with budeso
Page 45 and 46: Viral Infection Is a Common Cause o
Page 47 and 48: FACTORES RELACIONADOS CON EL INCUMP
Page 49 and 50: DARLE EDUCACION AL PACIENTE
Page 51 and 52: Manejo del médico Severidad Automa
Page 53 and 54: Chapter 4: Asthma management and pr
Page 55 and 56: GINA guidelines update 2005 Outcome
Page 57 and 58: • Farmacocinética-dinamia • Ef
Page 59 and 60: Esto llevó a hablar de: * United A
Page 61 and 62: ARIA 1- Por qué ARIA ? 2- Nueva cl
Page 63 and 64: Niveles de evidencia en el tratamie
Page 65 and 66: Tratamiento de la rinits alérgica
Page 67 and 68: Recomendaciones de la guia ARIA 1-
Page 69 and 70: Automanejo Educación
Page 71 and 72: Efectos clínicos de ICS en asma (2
Page 73 and 74: Asthma mortality, inhaled steroids,
Page 75 and 76: Reducción del riesgo de muerte Ca
Page 77 and 78: Antiasmhatic Drugs Sales in Argenti
Page 79 and 80: Guía Para el Manejo del Paso 3 de
Page 81: Table I. Estimates of the relative

Controladores

Create successful ePaper yourself

Delete template?

Save as template?